查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1454265

非侵入性血糖监测设备市场：按技术、按模式、按最终用户、按地区。

Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, By Modality, By End User, By Geography .
出版日期: | 出版商: Coherent Market Insights | 英文 163 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球非侵入性血糖监测设备市场价值为2,422万美元，2024年至2031年年复合成长率(CAGR)为15.7%，预计2031年将达到7,763万美元。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 2422万美元
实际资料 2019-2023 预测期 2024-2031
预测期2023/2024~2030/2031年复合成长率： 15.70% 2030/2031 年预测值 7763万美元
图 1. 2023 年非侵入性血糖监测设备的全球市场占有率（按地区划分）
非侵入性血糖监测设备市场-IMG1

非侵入性血糖监测，顾名思义，是指在不损伤人体组织的情况下检测血糖。与传统的指尖采血方法相比，非侵入性血糖监测设备提供了一种经济且无痛的血糖值监测方法。这些设备的工作原理是扫描皮肤附近的血管，而不是抽血。微创微针、近红外线光谱和超宽频雷达等葡萄糖检测技术的进步促进了非侵入性产品的开发，这些产品可以忠实地反映侵入性监测方法的测量结果。这为糖尿病患者管理病情提供了更大的便利性和依从性。非侵入性血糖监测设备依技术可分为电磁波、经皮、光学和酵素血糖监测设备。

市场动态：

非侵入性血糖监测设备市场是由全球糖尿病盛行率不断上升以及连续血糖监测技术的进步所推动的。许多新参与企业正在带着新颖的解决方案进入市场，这些解决方案有助于克服现有侵入性技术（例如手指刺穿）的挑战。然而，与参考方法相比，在实现高精度方面的技术限制、临床检验不足以及监管核准的延迟等因素继续限制了广泛普及。也就是说，专注于改进演算法和感测器的持续研究和开发为非侵入性解决方案提供了一个充满希望的机会，使其成为传统血糖测试的可行替代方案。

知识和诊断的缺乏预计将阻碍全球非侵入性血糖监测设备市场在预测期内的成长。

本研究的主要特点

  • 该报告对全球非侵入性血糖监测设备市场进行了详细分析，并提供了以2023年为基准年的预测期（2023-2031年）的市场规模和年复合成长率（CAGR%）。
  • 它阐明了不同细分市场的潜在收益成长机会，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球非侵入性血糖监测设备市场的主要企业。
  • 本研究报告中介绍的主要企业包括Baxter International Inc.、Dexcom, Inc.、Abbott、Medtronic、Senseonics Holdings, Inc.、GlySens Incorporated、DiaMonTech GmbH、Nemaura Medical Inc.、Integrity Applications, Inc.、CNOGA Medical Ltd. 。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球非侵入性血糖监测设备市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
  • 需要新斯的明的重症肌无力和术后肠阻塞等疾病的盛行率增加
    • 抑制因素
  • 缺乏知识和诊断
    • 机会
  • 兽医医学的发展
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章全球非侵入性血糖监测设备市场 - 冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球非侵入性血糖监测设备市场（按技术）2019-2031

  • 电磁波
  • 经皮的
  • 光学
  • 酵素

第六章 全球非侵入性血糖监测设备市场（按模式），2019-2031

  • 穿戴式的
  • 非配戴式/桌上型
  • 嵌入式装置

第七章 全球非侵入性血糖监测设备市场，依最终用户划分，2019-2031

  • 医院
  • 诊所
  • 居家照护环境

第八章2019-2031年全球非侵入性血糖监测设备市场（按地区）

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东和非洲
  • GCC
  • 以色列
  • 其他中东地区
  • 北非
  • 中部非洲
  • 南非

第9章 竞争格局

  • Baxter International Inc.
  • Dexcom, Inc
  • Abbott
  • Medtronic
  • Senseonics Holdings, Inc
  • GlySens Incorporated
  • DiaMonTech GmbH
  • Nemaura Medical Inc.
  • Integrity Applications, Inc.
  • CNOGA Medical Ltd
  • Breath Health, Inc.
  • Metamaterial Technologies Inc.
  • Opticology Inc.
  • NovioSense BV
  • Quick LLC
  • RSP Systems A/S.

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI1480

The global non-invasive blood glucose monitoring devices market was valued US$ 24.22 Mn in 2023 and is expected to reach US$ 77.63 Mn by 2031 growing at a compound annual growth rate (CAGR) of 15.7% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 24.22 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 15.70% 2030/2031 Value Projection: US$ 77.63 Mn
Figure 1. Global Non-Invasive Blood Glucose Monitoring Devices Market Share (%), by Region, 2023
Non-Invasive Blood Glucose Monitoring Devices Market - IMG1

Non-invasive blood glucose monitoring, as its name implies, refers to the detection of human blood glucose without causing damage to human tissues. Non-invasive blood glucose monitoring devices offer an economical and pain-free method to monitor blood glucose levels compared to traditional finger-pricking methods. These devices work by scanning the blood vessels near the skin instead of drawing blood. Advancement in glucose sensing technologies, such as minimally-invasive micro needles, near infrared spectroscopy, and ultra wideband radar, have facilitated the development of non-invasive products that can closely mirror readings from invasive monitoring methods. This provides diabetics with greater convenience and compliance in managing their condition. Non-invasive blood glucose monitoring devices can be segmented on the basis of technology into EM waves, transdermal, optical, and enzymatic.

Market Dynamics:

The non-invasive blood glucose monitoring devices market is driven by the growing prevalence of diabetes worldwide as well as advancements in continuous glucose monitoring technologies. Many new players are entering the market with novel solutions that can help overcome the challenges with existing invasive methods like finger pricks. However, factors such as technical limitations in achieving high accuracy compared to reference methods, insufficient clinical validation, and slow regulatory approvals continue to restrain widespread adoption. Nonetheless, continued R&D focusing on improved algorithms and sensors offers promising opportunities for non-invasive solutions to become a viable alternative to conventional glucose tests.

Lack of knowledge and diagnosis are expected to hamper the growth of the global non-invasive blood glucose monitoring devices market over the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global non-invasive blood glucose monitoring devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2031), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global non-invasive blood glucose monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Baxter International Inc., Dexcom, Inc, Abbott, Medtronic, Senseonics Holdings, Inc, GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global non-invasive blood glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non-invasive blood glucose monitoring devices market

Detailed Segmentation:

  • Global non-invasive blood glucose monitoring devices Market, By Technology:
    • EM Waves
    • Transdermal
    • Optical
    • Enzymatic
  • Global non-invasive blood glucose monitoring devices Market, By Modality:
    • Wearable
    • Non-wearable/Benchtop
    • Embedded Devices
  • Global non-invasive blood glucose monitoring devices Market, By End User:
    • Hospitals
    • Clinics
    • Homecare setting
  • Global non-invasive blood glucose monitoring devices Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profile:
    • Baxter International Inc.
    • Dexcom, Inc
    • Abbott
    • Medtronic
    • Senseonics Holdings, Inc
    • GlySens Incorporated
    • DiaMonTech GmbH
    • Nemaura Medical Inc.
    • Integrity Applications, Inc.
    • CNOGA Medical Ltd.
    • Breath Health, Inc.
    • Metamaterial Technologies Inc.
    • Opticology Inc.
    • NovioSense BV
    • Quick LLC
    • RSP Systems A/S.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Modality
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rising prevalence of diseases like myasthenia gravis and postoperative ileus requiring neostigmine
    • Restraints
  • Lack of knowledge and diagnosis
    • Opportunities
  • The growth of veterinary medicine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Non-Invasive Blood Glucose Monitoring Devices Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • EM Waves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Transdermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Optical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Enzymatic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Modality, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Wearable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Non-wearable/Benchtop
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Embedded Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Non-Invasive Blood Glucose Monitoring Devices Market, By End User, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Homecare setting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Region, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country 2020 -2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub Region, 2019-2031,(US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dexcom, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Senseonics Holdings, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlySens Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DiaMonTech GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nemaura Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Integrity Applications, Inc.
  • CNOGA Medical Ltd
  • Breath Health, Inc.
  • Metamaterial Technologies Inc.
  • Opticology Inc.
  • NovioSense BV
  • Quick LLC
  • RSP Systems A/S.
  • Analyst Views

10. Section

  • Research Methodology
  • About us